MeiraGTx Holdings plcMGTXEarnings & Financial Report

Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)

Deep AnalysisCompare

MeiraGTx Holdings plc is a clinical-stage biotechnology firm specializing in the research, development and commercialization of transformative gene therapies. Its core pipeline targets rare ophthalmic conditions, neurodegenerative disorders, and salivary gland diseases, serving patients across global markets with operations in the U.S. and European Union.